CIK 0001651308
- Large accelerated filer
BeOne Medicines Ltd.
Sign in to watch- Ticker
- BEIGF
- Exchange
- Nasdaq, OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 981209416
- Phone
- +41 616851900
- Business address
- C/O BEONE MEDICINES I GMBH, AESCHENGRABEN 27, 21ST FLOOR, BASEL, Switzerland, 4051
- Former names
- BeiGene, Ltd.
Securities
- ONC American Depositary Shares Nasdaq
- BEIGF Common stock OTC
- 4 Open-market sale Director sold 10,000 shares at $169.84 ($1,698,400)
- 4 Open-market sale Chief Executive Officer sold 4,635 shares at an average $141.43 ($655,537)
- 4 Open-market sale President & GM China sold 7,024 shares at an average $141.33 ($992,711)
- 4 Open-market sale CMO, Hematology sold 1,500 shares at $162.30 ($243,450)
- 4 Open-market sale CMO, Hematology sold 1,500 shares at $160.00 ($240,000)
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale Director sold 5,000 shares at an average $157.14 ($785,681)
- 4 Derivatives Options or other derivatives
- 4 Open-market sale CMO, Hematology sold 1,500 shares at an average $170.25 ($255,380)
- 4 Open-market sale CMO, Hematology sold 1,500 shares at an average $170.69 ($256,042)
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale Chief Executive Officer sold 62,259 shares at an average $160.62 ($10,000,100)
- 4 Open-market sale CMO, Hematology sold 1,500 shares at an average $165.14 ($247,710)
- 4 Gift Director gave 81,060 shares (gift)
- 4 Open-market sale CFO & Chief Strategy Officer sold 25,000 shares at an average $194.34 ($4,858,616)
- 4 Open-market sale CMO, Hematology sold 1,500 shares at an average $194.49 ($291,740)
- 4 Open-market sale Director sold 13,000 shares at an average $194.63 ($2,530,198)
- 4 Open-market sale President & GM China sold 1,000 shares at $202.05 ($202,050)
- 4 Open-market sale CMO, Hematology sold 32,900 shares at an average $190.46 ($6,266,007)
Page 21 of 29 · 580 filings